Shanghai Feiwei Information Technology has raised 100 million yuan ($15 million) in a Series B round of financing co-led by Redpoint China Ventures and GP Capital, while Zeesan Biotech has garnered $10 million from Sinovation Ventures.
Shanghai Feiwei bags $15m in a Series B round
Big data services specialist Shanghai Feiwei Information Technology Co., Ltd has announced the completion of a 100 million yuan ($15 million) Series B round co-led by Redpoint China Ventures and GP Capital, a state-backed fund jointly launched by Shanghai International Group and Huatai Securities in 2009.
